Nymox Pharmaceutical
NYMX
#9797
Rank
โ‚ฌ17.53 M
Marketcap
Country
0,19ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -โ‚ฌ2.11 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -โ‚ฌ6.27 Million, an increase over its 2021 earnings that were of -โ‚ฌ11.99 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚ฌ2.11 Million-66.4%
2022 -โ‚ฌ6.27 Million-47.71%
2021 -โ‚ฌ11.99 Million6.61%
2020 -โ‚ฌ11.25 Million-10.91%
2019 -โ‚ฌ12.63 Million24.24%
2018 -โ‚ฌ10.16 Million-20.03%
2017 -โ‚ฌ12.71 Million2.71%
2016 -โ‚ฌ12.37 Million-63.86%
2015 -โ‚ฌ34.23 Million674.44%
2014 -โ‚ฌ4.42 Million-6.11%
2013 -โ‚ฌ4.71 Million-35.66%
2012 -โ‚ฌ7.32 Million-20.76%
2011 -โ‚ฌ9.24 Million38.33%
2010 -โ‚ฌ6.68 Million35.59%
2009 -โ‚ฌ4.93 Million11.8%
2008 -โ‚ฌ4.41 Million-12.94%
2007 -โ‚ฌ5.06 Million8.85%
2006 -โ‚ฌ4.65 Million36.5%
2005 -โ‚ฌ3.41 Million-4.4%
2004 -โ‚ฌ3.57 Million-14.58%
2003 -โ‚ฌ4.17 Million
2001 -โ‚ฌ3.06 Million-20.54%
2000 -โ‚ฌ3.85 Million21.72%
1999 -โ‚ฌ3.17 Million-25.56%
1998 -โ‚ฌ4.25 Million101.3%
1997 -โ‚ฌ2.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ6.51 B-313,751.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.66 B-321,386.44%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.06 B-51,603.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.75 B-469,813.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ17.67 B-851,326.28%๐Ÿ‡บ๐Ÿ‡ธ USA